275 related articles for article (PubMed ID: 16281487)
1. [Apolipoprotein B100 as a risk factor of acute coronary syndrome and this risk factor effect on arterial hypertension in patients with ischemic heart disease].
Arabidze GG; Pokrovskiĭ SN; Afanas'eva MI; Tebloev KI; Memetov KA; Skriabina EO
Ter Arkh; 2005; 77(9):35-9. PubMed ID: 16281487
[TBL] [Abstract][Full Text] [Related]
2. Apolipoproteins A-I and B-markers in coronary risk evaluation.
Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
[TBL] [Abstract][Full Text] [Related]
3. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
4. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
Benn M; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):661-70. PubMed ID: 17170368
[TBL] [Abstract][Full Text] [Related]
5. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
Rasouli M; Kiasari AM
Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
[TBL] [Abstract][Full Text] [Related]
6. [Underrecognized peripheral arterial disease in patients with acute coronary syndrome: prevalence of traditional and emergent cardiovascular risk factors].
Huelmos A; Jiménez J; Guijarro C; Belinchón JC; Puras E; Sánchez C; Casas ML; López-Bescos L
Rev Esp Cardiol; 2005 Dec; 58(12):1403-10. PubMed ID: 16371199
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of emotions as a risk factor for ischemic heart disease.
Marusic A; Belsak K; Marusic D
Psychiatr Danub; 2008 Mar; 20(1):31-6. PubMed ID: 18376328
[TBL] [Abstract][Full Text] [Related]
8. ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease.
Sabino AP; De Oliveira Sousa M; Moreira Lima L; Dias Ribeiro D; Sant'Ana Dusse LM; Das Graças Carvalho M; Fernandes AP
Transl Res; 2008 Sep; 152(3):113-8. PubMed ID: 18774540
[TBL] [Abstract][Full Text] [Related]
9. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
Carević V; Rumboldt M; Rumboldt Z;
Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
[TBL] [Abstract][Full Text] [Related]
10. [Ischemic heart disease and metabolic syndrome X (family study)].
Lifshits GI; Nikolaev KIu; Oteva EA; Nikolaeva AA
Ter Arkh; 2000; 72(12):10-3. PubMed ID: 11201819
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients.
Oldgren J; James SK; Siegbahn A; Wallentin L
Eur Heart J; 2007 Mar; 28(6):699-704. PubMed ID: 17314110
[TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
13. [The relationship of apolipoprotein A-I and B-100 to cardiovascular diseases in aging males].
Hu XL; Bao WD; Song FR
Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Feb; 16(1):11-3. PubMed ID: 7767918
[TBL] [Abstract][Full Text] [Related]
14. Acute coronary syndromes and other forms of coronary heart disease in the National Health Service, 1997-2001.
Gíria J; Catarino J; Rocha E
Rev Port Cardiol; 2004 Jun; 23(6):883-92. PubMed ID: 15376734
[TBL] [Abstract][Full Text] [Related]
15. [Correlations between electrophysiological myocardial remodeling and parameters of free radical oxidation in patients with various forms of ischemic heart disease].
Drinitsina SV; Azizova OA; Piriazev AP; Korinevich AIu; Solov'eva NP; Ivanov GG; Lopukhin IuM
Ter Arkh; 2006; 78(12):27-35. PubMed ID: 17294860
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for acute myocardial infarction among Okinawans.
Tokuda Y
J Nutr Health Aging; 2005; 9(4):272-6. PubMed ID: 15980929
[TBL] [Abstract][Full Text] [Related]
17. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.
Laghrissi-Thode F; Wagner WR; Pollock BG; Johnson PC; Finkel MS
Biol Psychiatry; 1997 Aug; 42(4):290-5. PubMed ID: 9270907
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of lipid plasma spectrum and basic parameters of red cell membranes in patients with metabolic syndrome and ischemic heart disease].
Medvedeva IV; Dorodneva EF; Pugacheva TA; Belokorylova LV; Shorokhova TD; Ushakova MA
Klin Med (Mosk); 2002; 80(5):27-30. PubMed ID: 12087882
[TBL] [Abstract][Full Text] [Related]
19. [Changes of blood lipids and apolipoproteins in patients with silent myocardial ischemia].
Tan M; Zhao S; Yu S
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):44-6, 56. PubMed ID: 10681793
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin E in patients with ischemic heart disease.
Sinkiewicz W; Błazejewski J; Bujak R; Kubica J; Dudziak J
Cardiol J; 2008; 15(2):122-8. PubMed ID: 18651396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
